Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-27

Clinical Trial Update: The Effect of Arginine on Classic Galactosemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effect of arginine on classic galactosemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arginine (L-Arginine)

Snippet

Sponsor: Academisch Ziekenhuis Maastricht | Conditions: Classic Galactosemia | Phase 2 | Status: COMPLETED